Pembrolizumab: First Global Approval

Overview of attention for article published in Drugs, October 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 2 X users

patent: 4 patents

Citations

dimensions_citation: 140 Dimensions

Readers on

mendeley: 137 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-P…

Grant US-11845798-B2

United States of America

Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use…

Grant US-11633476-B2

United States of America

Compositions comprising bacterial strains

Grant US-11433106-B2

United States of America

Humanized antibodies to LIV-1 and use of same to treat cancer

Grant US-RE48959-E1

United States of America